Literature DB >> 16344603

Glycine as a therapeutic immuno-nutrient for alcoholic liver disease.

Shunhei Yamashina1, Kenichi Ikejima, Nobuyuki Enomoto, Yoshiyuki Takei, Nobuhiro Sato.   

Abstract

Activation of Kupffer cells by gut-derived endotoxin is an important factor in ethanol hepatotoxicity. Further, it was shown that ethanol modulates both the expression and activity of several intracellular signaling molecules and transcription factors in Kupffer cells and chronic ethanol treatment enhances Kupffer cell sensitivity to endotoxin. These findings suggest that inhibition of Kupffer cell activation is effective for clinical application in alcoholic hepatitis. Recently, accumulating lines of evidence suggest a possibility that glycine is useful as an immuno-modulating amino acid. It has been shown that a diet containing glycine improved survival in endotoxin shock by preventing Kupffer cell activation. Glycine most likely prevents the LPS-induced elevation of intracellular Ca concentration in Kupffer cells, thereby minimizing LPS receptor signaling and cytokine production. Indeed, glycine prevents alcohol-induced liver injury in a long-term enteral ethanol feeding rats (Tsukamoto-French) by decreasing production of TNF-alpha in the liver. Moreover, glycine is protective against apoptosis of sinusoidal endothelial cells (SECs) that is one of the initial events in the development of liver injury. On the other hand, epidemiologic data have identified chronic alcohol consumption as a significant risk factor for carcinogenesis. Interestingly, glycine inhibits growth of tumor in vivo most likely because of the inhibition of angiogenesis. It was shown that the inhibitory effect of glycine on growth and migration of endothelial cells is due to activation of a glycine-gated Cl channel. It is hypothesized that the opening of this anion channel hyperpolarizes the cell membrane, blocks influx of Ca through voltage-dependent Ca channel, thereby blunting growth factor-mediated signaling. Therefore, glycine can be used not only for treatment of alcoholic hepatitis, but also for chemoprevention and treatment of hepatocellular carcinoma in alcoholic cirrhosis. Taken together, it is concluded that glycine is a potent therapeutic immuno-nutrient for various kinds of chronic liver diseases including alcoholic liver disease (ALD).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344603     DOI: 10.1097/01.alc.0000189281.82523.6c

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  9 in total

1.  Role of oil vehicle on hepatic cell proliferation in PCB-treated rats.

Authors:  Rodica Petruta Bunaciu; Job C Tharappel; Hans-Joachim Lehmler; Eun Y Lee; Larry W Robertson; Geza G Bruckner; Brett T Spear; Howard P Glauert
Journal:  J Environ Pathol Toxicol Oncol       Date:  2011       Impact factor: 3.567

2.  Ameliorative effects of glycine in an experimental nonalcoholic steatohepatitis and its correlation between TREM-1 and TREM-2.

Authors:  Zhang-Feng Dou; Ya-Rong Guo; Jin-Chun Liu; Ning Li; Bao Chai; Xiu-Qing Li; Rong Fu; Xiao-Juan Wang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

3.  Glycine enhances microglial intracellular calcium signaling. A role for sodium-coupled neutral amino acid transporters.

Authors:  Jimmy Van den Eynden; Kristof Notelaers; Bert Brône; Daniel Janssen; Katherine Nelissen; Sheen Sahebali; Inge Smolders; Niels Hellings; Paul Steels; Jean-Michel Rigo
Journal:  Pflugers Arch       Date:  2011-02-25       Impact factor: 3.657

4.  The effect of dietary glycine on the hepatic tumor promoting activity of polychlorinated biphenyls (PCBs) in rats.

Authors:  Rodica Petruta Bunaciu; Job C Tharappel; Hans-Joachim Lehmler; Izabela Kania-Korwel; Larry W Robertson; Cidambi Srinivasan; Brett T Spear; Howard P Glauert
Journal:  Toxicology       Date:  2007-07-07       Impact factor: 4.221

5.  Plasma metabolomic profiling of dairy cows affected with ketosis using gas chromatography/mass spectrometry.

Authors:  Hongyou Zhang; Ling Wu; Chuang Xu; Cheng Xia; Lingwei Sun; Shi Shu
Journal:  BMC Vet Res       Date:  2013-09-26       Impact factor: 2.741

6.  The cardiometabolic benefits of glycine: Is glycine an 'antidote' to dietary fructose?

Authors:  Mark F McCarty; James J DiNicolantonio
Journal:  Open Heart       Date:  2014-05-28

7.  Glycine and glycine receptor signalling in non-neuronal cells.

Authors:  Jimmy Van den Eynden; Sheen Saheb Ali; Nikki Horwood; Sofie Carmans; Bert Brône; Niels Hellings; Paul Steels; Robert J Harvey; Jean-Michel Rigo
Journal:  Front Mol Neurosci       Date:  2009-08-20       Impact factor: 5.639

Review 8.  Dietary Glycine Is Rate-Limiting for Glutathione Synthesis and May Have Broad Potential for Health Protection.

Authors:  Mark F McCarty; James H O'Keefe; James J DiNicolantonio
Journal:  Ochsner J       Date:  2018

9.  Predicting metabolite-disease associations based on KATZ model.

Authors:  Xiujuan Lei; Cheng Zhang
Journal:  BioData Min       Date:  2019-10-26       Impact factor: 2.522

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.